IPO Roundup: Viking Holdings, RanMarine Technology, and more
- Resilience in IPO Market: Despite uncertainty around interest rate cuts, IPO market remains strong with companies like Rubrik pricing its IPO higher than expected and performing well.
- Current IPO Market Performance: The Renaissance IPO ETF is down by 3.69%, lagging behind the S&P 500's YTD return of 6.92%.
- Upcoming IPOs: Several companies are preparing for IPOs this week, including Viking Holdings, RanMarine Technology, Key Mining, NANO Nuclear Energy, and Ale Group Holdings.
- New Filings: Super Hi International Holding and Fintech Scion have filed for IPOs to raise funds, planning to list on Nasdaq under the symbols HDL and FINR respectively.
- Terms and Changes: Companies like Correlate Energy, Autozi Internet Technology, Lafayette Energy, and TessPay have made revisions to their IPO terms and deal sizes.
Trade with 70% Backtested Accuracy
Analyst Views on ATGL
About ATGL
About the author
Sarepta Therapeutics Reports Significant Three-Year Study Results
- Clinical Trial Results: Sarepta Therapeutics reported significant three-year results from the EMBARK study, showing that patients treated with Elevidys demonstrated statistically significant efficacy in motor function assessments, leading to a 9.8% stock price increase to $23.20, indicating enhanced competitiveness in Duchenne muscular dystrophy treatment.
- Positive Market Reaction: Following the release of favorable clinical data, there was a surge in demand for Sarepta's shares, reflecting investor optimism about the biopharmaceutical sector's outlook, which may attract more capital into the industry.
- Industry Impact: Sarepta's success could inspire other biopharmaceutical companies to increase investments in rare disease research and development, thereby fostering innovation and growth across the sector.
- Investor Confidence Boost: The success story of Sarepta may bolster investor confidence in biotech stocks, particularly as market conditions continue to favor increased focus on the healthcare sector.
U.S. Nonfarm Payrolls Increase by 50,000, Unemployment Rate Drops to 4.4%
- Labor Market Stability: According to the Bureau of Labor Statistics, nonfarm payrolls increased by 50,000 in December 2025, remaining largely unchanged from November's downwardly revised gain of 56,000, although slightly below the expected 60,000, indicating resilience in the labor market and easing concerns about rising unemployment.
- Unemployment Rate Decline: The unemployment rate fell from a revised 4.5% in November to 4.4%, landing below expectations of 4.5%, suggesting improvements in the labor market that could support consumer confidence and spending.
- Wage Growth Acceleration: Average hourly earnings rose by 0.3% month-over-month, accelerating from November's 0.2% increase and matching forecasts, which may drive consumer spending and bolster economic growth.
- Housing Market Slowdown: Housing starts declined by 4.6% from the previous month to an annualized rate of 1.246 million units, while building permits fell by 0.2% to an annualized rate of 1.412 million, indicating a slowdown in the real estate market that could impact the overall pace of economic recovery.
Major Stocks Including Helmerich and Payne, Invivyd, and Home Depot Decline in Tuesday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are down, with Dow futures dropping approximately 200 points on Tuesday morning.
Helmerich and Payne Inc: The company reported a fourth-quarter loss of 1 cent per share despite quarterly sales of $1.012 billion, leading to a 7% drop in its shares during pre-market trading.
Other Stocks Declining: Several other stocks, including Alpha Technology Group Ltd and Invivyd Inc, experienced significant declines in pre-market trading, with drops of 19% and 13.4%, respectively.
Home Depot's Performance: Home Depot's shares fell 2% after reporting worse-than-expected third-quarter adjusted EPS and lowering its FY25 adjusted EPS outlook.
Gorilla Technology Shares Rise Approximately 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Gorilla Technology Group Performance: Gorilla Technology Group Inc. reported a 32% year-over-year revenue increase to $26.5 million for Q3, leading to a 13.7% rise in its share price during pre-market trading.
Other Gainers in Pre-Market Trading: Notable stocks that surged include Olema Pharmaceuticals (up 53%), Lobo Technologies (up 40.3%), and Aspire Biopharma (up 30.7%), among others.
Losers in Pre-Market Trading: LifeMD Inc. saw a significant drop of 26.2% after disappointing financial results, while Alpha Technology Group and NextPlat Corp also experienced notable declines.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies reporting strong earnings while others faced setbacks.
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. Stock Market Update: U.S. stock futures rose this morning, with Dow futures up about 0.2%, while several companies, including Absci Corporation and Regencell Bioscience Holdings, saw significant declines in their pre-market trading due to disappointing financial results.
Notable Stock Movements: Absci's shares fell 9.4% after reporting losses that missed analyst expectations, alongside other stocks like HealthEquity and Turkcell experiencing notable drops of 14.7% and 14.8%, respectively, following poor earnings reports.
AB DAO Partners with Alpha Technology to Pioneer the AI+Blockchain Era
Partnership Announcement: AB DAO has partnered with Alpha Technology Group Limited to enhance the integration of artificial intelligence and blockchain technology in supply chain management, enterprise operations, and IoT applications.
Ecosystem Expansion: AB DAO is expanding its ecosystem by listing its token $AB on multiple exchanges, aiming for a goal of 100 million holders while showcasing its innovative products like smart energy meters and payment kiosks.
Sarepta Therapeutics Reports Significant Three-Year Study Results
- Clinical Trial Results: Sarepta Therapeutics reported significant three-year results from the EMBARK study, showing that patients treated with Elevidys demonstrated statistically significant efficacy in motor function assessments, leading to a 9.8% stock price increase to $23.20, indicating enhanced competitiveness in Duchenne muscular dystrophy treatment.
- Positive Market Reaction: Following the release of favorable clinical data, there was a surge in demand for Sarepta's shares, reflecting investor optimism about the biopharmaceutical sector's outlook, which may attract more capital into the industry.
- Industry Impact: Sarepta's success could inspire other biopharmaceutical companies to increase investments in rare disease research and development, thereby fostering innovation and growth across the sector.
- Investor Confidence Boost: The success story of Sarepta may bolster investor confidence in biotech stocks, particularly as market conditions continue to favor increased focus on the healthcare sector.
U.S. Nonfarm Payrolls Increase by 50,000, Unemployment Rate Drops to 4.4%
- Labor Market Stability: According to the Bureau of Labor Statistics, nonfarm payrolls increased by 50,000 in December 2025, remaining largely unchanged from November's downwardly revised gain of 56,000, although slightly below the expected 60,000, indicating resilience in the labor market and easing concerns about rising unemployment.
- Unemployment Rate Decline: The unemployment rate fell from a revised 4.5% in November to 4.4%, landing below expectations of 4.5%, suggesting improvements in the labor market that could support consumer confidence and spending.
- Wage Growth Acceleration: Average hourly earnings rose by 0.3% month-over-month, accelerating from November's 0.2% increase and matching forecasts, which may drive consumer spending and bolster economic growth.
- Housing Market Slowdown: Housing starts declined by 4.6% from the previous month to an annualized rate of 1.246 million units, while building permits fell by 0.2% to an annualized rate of 1.412 million, indicating a slowdown in the real estate market that could impact the overall pace of economic recovery.
Major Stocks Including Helmerich and Payne, Invivyd, and Home Depot Decline in Tuesday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are down, with Dow futures dropping approximately 200 points on Tuesday morning.
Helmerich and Payne Inc: The company reported a fourth-quarter loss of 1 cent per share despite quarterly sales of $1.012 billion, leading to a 7% drop in its shares during pre-market trading.
Other Stocks Declining: Several other stocks, including Alpha Technology Group Ltd and Invivyd Inc, experienced significant declines in pre-market trading, with drops of 19% and 13.4%, respectively.
Home Depot's Performance: Home Depot's shares fell 2% after reporting worse-than-expected third-quarter adjusted EPS and lowering its FY25 adjusted EPS outlook.
Gorilla Technology Shares Rise Approximately 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Gorilla Technology Group Performance: Gorilla Technology Group Inc. reported a 32% year-over-year revenue increase to $26.5 million for Q3, leading to a 13.7% rise in its share price during pre-market trading.
Other Gainers in Pre-Market Trading: Notable stocks that surged include Olema Pharmaceuticals (up 53%), Lobo Technologies (up 40.3%), and Aspire Biopharma (up 30.7%), among others.
Losers in Pre-Market Trading: LifeMD Inc. saw a significant drop of 26.2% after disappointing financial results, while Alpha Technology Group and NextPlat Corp also experienced notable declines.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies reporting strong earnings while others faced setbacks.
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. Stock Market Update: U.S. stock futures rose this morning, with Dow futures up about 0.2%, while several companies, including Absci Corporation and Regencell Bioscience Holdings, saw significant declines in their pre-market trading due to disappointing financial results.
Notable Stock Movements: Absci's shares fell 9.4% after reporting losses that missed analyst expectations, alongside other stocks like HealthEquity and Turkcell experiencing notable drops of 14.7% and 14.8%, respectively, following poor earnings reports.
AB DAO Partners with Alpha Technology to Pioneer the AI+Blockchain Era
Partnership Announcement: AB DAO has partnered with Alpha Technology Group Limited to enhance the integration of artificial intelligence and blockchain technology in supply chain management, enterprise operations, and IoT applications.
Ecosystem Expansion: AB DAO is expanding its ecosystem by listing its token $AB on multiple exchanges, aiming for a goal of 100 million holders while showcasing its innovative products like smart energy meters and payment kiosks.
